These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 31079550)

  • 1. Identifying the Transcriptome Signatures of Calcium Channel Blockers in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Lam CK; Tian L; Belbachir N; Wnorowski A; Shrestha R; Ma N; Kitani T; Rhee JW; Wu JC
    Circ Res; 2019 Jul; 125(2):212-222. PubMed ID: 31079550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolving the Reversed Rate Effect of Calcium Channel Blockers on Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes and the Impact on In Vitro Cardiac Safety Evaluation.
    Zeng H; Wang J; Clouse H; Lagrutta A; Sannajust F
    Toxicol Sci; 2019 Feb; 167(2):573-580. PubMed ID: 30365015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling of calcium-channel antagonists in the heart of hypertensive and normotensive rats reveals class specific effects.
    Zwadlo C; Borlak J
    Vascul Pharmacol; 2016 Dec; 87():121-128. PubMed ID: 27613148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different effects of calcium channel blockers on matrix metalloproteinase-2 expression in cultured rat cardiac fibroblasts.
    Yue H; Uzui H; Shimizu H; Nakano A; Mitsuke Y; Ueda T; Lee JD
    J Cardiovasc Pharmacol; 2004 Aug; 44(2):223-30. PubMed ID: 15243304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.
    Altomare C; Pianezzi E; Cervio E; Bolis S; Biemmi V; Benzoni P; Camici GG; Moccetti T; Barile L; Vassalli G
    Europace; 2016 Dec; 18(suppl 4):iv67-iv76. PubMed ID: 28011833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The L-type Ca2+ channels blocker nifedipine represses mesodermal fate determination in murine embryonic stem cells.
    Nguemo F; Fleischmann BK; Gupta MK; Sarić T; Malan D; Liang H; Pfannkuche K; Bloch W; Schunkert H; Hescheler J; Reppel M
    PLoS One; 2013; 8(1):e53407. PubMed ID: 23320083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium-channel-blockers exhibit divergent regulation of cancer extravasation through the mechanical properties of cancer cells and underlying vascular endothelial cells.
    Vaibavi SR; Sivasubramaniapandian M; Vaippully R; Edwina P; Roy B; Bajpai SK
    Cell Biochem Biophys; 2022 Mar; 80(1):171-190. PubMed ID: 34643835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of [3H]-U69593 binding and the cardiac effects of U50, 488H by calcium channel blockers in the rat heart.
    Zhang WM; Wang HX; Xia Q; Wong TM
    Br J Pharmacol; 1997 Mar; 120(5):827-32. PubMed ID: 9138688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between amiodarone and hepatitis-C virus nucleotide inhibitors in human induced pluripotent stem cell-derived cardiomyocytes and HEK-293 Cav1.2 over-expressing cells.
    Lagrutta A; Zeng H; Imredy J; Balasubramanian B; Dech S; Lis E; Wang J; Zhai J; DeGeorge J; Sannajust F
    Toxicol Appl Pharmacol; 2016 Oct; 308():66-76. PubMed ID: 27520758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Batch Variations in Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes from 2 Major Suppliers.
    Huo J; Kamalakar A; Yang X; Word B; Stockbridge N; Lyn-Cook B; Pang L
    Toxicol Sci; 2017 Mar; 156(1):25-38. PubMed ID: 28031415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium channel blockers differentially modulate cytokine production by peripheral blood mononuclear cells.
    Matsumori A; Nishio R; Nose Y
    Circ J; 2010 Mar; 74(3):567-71. PubMed ID: 20118567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stiff matrix induces switch to pure β-cardiac myosin heavy chain expression in human ESC-derived cardiomyocytes.
    Weber N; Schwanke K; Greten S; Wendland M; Iorga B; Fischer M; Geers-Knörr C; Hegermann J; Wrede C; Fiedler J; Kempf H; Franke A; Piep B; Pfanne A; Thum T; Martin U; Brenner B; Zweigerdt R; Kraft T
    Basic Res Cardiol; 2016 Nov; 111(6):68. PubMed ID: 27743117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ca²⁺ channel activators reveal differential L-type Ca²⁺ channel pharmacology between native and stem cell-derived cardiomyocytes.
    Kang J; Chen XL; Ji J; Lei Q; Rampe D
    J Pharmacol Exp Ther; 2012 May; 341(2):510-7. PubMed ID: 22353878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep phenotyping of human induced pluripotent stem cell-derived atrial and ventricular cardiomyocytes.
    Cyganek L; Tiburcy M; Sekeres K; Gerstenberg K; Bohnenberger H; Lenz C; Henze S; Stauske M; Salinas G; Zimmermann WH; Hasenfuss G; Guan K
    JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by verapamil and diltiazem of agonist-stimulated contractile responses in mammalian ventricular cardiomyocytes.
    Bell D; McDermott BJ
    J Mol Cell Cardiol; 1995 Sep; 27(9):1977-87. PubMed ID: 8523457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preservation of cardiomyocytes from the adult heart.
    Abi-Gerges N; Pointon A; Pullen GF; Morton MJ; Oldman KL; Armstrong D; Valentin JP; Pollard CE
    J Mol Cell Cardiol; 2013 Nov; 64():108-19. PubMed ID: 24051370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice.
    Stöhr A; Friedrich FW; Flenner F; Geertz B; Eder A; Schaaf S; Hirt MN; Uebeler J; Schlossarek S; Carrier L; Hansen A; Eschenhagen T
    J Mol Cell Cardiol; 2013 Oct; 63():189-98. PubMed ID: 23896226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult human cardiac stem cell supplementation effectively increases contractile function and maturation in human engineered cardiac tissues.
    Murphy JF; Mayourian J; Stillitano F; Munawar S; Broughton KM; Agullo-Pascual E; Sussman MA; Hajjar RJ; Costa KD; Turnbull IC
    Stem Cell Res Ther; 2019 Dec; 10(1):373. PubMed ID: 31801634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.